# First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-line-combination-therapy-with-rituximab-and-corticosteroids-provides-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yung‐Tsu Cho,Chia‐Yu Chu,Lifang Wang |
| Citations | 67 |
| DOI | 10.1111/bjd.13633 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2077735806 |
| PMID | 25529394 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Yung‐Tsu Cho](https://scholariq.org/researchers/yung-tsu-cho/)

## Paper journal

- [British Journal of Dermatology](https://scholariq.org/journals/british-journal-of-dermatology/)

## Paper primary topic

- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Paper topics

- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.